Dela Peña, Anita .
HRN: 26-30-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/29/2024
12/13/2024
IV
2.25g
Q8H
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes